The epidemic in 2020 has aroused great attention to the big health industry in China

The epidemic in 2020 has aroused great attention to the big health industry in China, which is an unprecedented national health education, and people are expected to continue to increase the health consumption expenditure. Enterprises across the country have shown good social responsibility, rapid innovation and positive clinical role in this outbreak, which will enhance investors" confidence in the field of big health. The outbreak has led to a qualitative leap in the innovative development of products and services related to big health, with new products and more nuanced services emerging in an endless stream. Medical devices, biotechnology, innovative medicine, genetic testing, health management, telemedicine, diagnosis, the Chinese medicine industry and other health services innovation is obvious.